Evaluating a new decision support tool for diagnosing blood clots

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the diagnostic performance of a Clinical Decision Support tool using fresh plasma samples compared to frozen plasma samples in patients suspected of having venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT). The study will analyze various patient subpopulations, including those with different clinical probabilities and specific conditions such as active cancer or COVID-19. Participants will receive standard care while their diagnostic outcomes are evaluated against established reference diagnoses.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* PE and/or DVT suspicion
* No opposition after informing the patient for his participation in research and processing of their data for this purpose,
* Benefiting from the social security system

Exclusion Criteria:

* Preventive or curative anticoagulant treatment, or fibrinolytic treatment,
* Legal protection (e.g. guardianship or curatorship),
* Pregnant or breastfeeding women.

Where it's running

• Centre Hospitalier de Niort
  Niort, Sartres, France Recruiting
• Centre Hospitalier le Mans
  Le Mans, Sartre, France Recruiting
• CHU Dijon Bourgogne
  Dijon, France Recruiting
• University Hospital Grenoble
  Grenoble, France Recruiting

Study contacts

• Principal investigator: Vincent Violeau — Centre Hospitalier de Niort
• Study coordinator: Aurelie Lamielle
• Email: aurelie.lamielle@stago.com
• Phone: 0141471500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Timing of anticoagulation for preventing blood clots in patients with brain hemorrhage

  This study is testing whether starting blood-thinning treatment early or later can help prevent blood clots in patients with bleeding in the brain while keeping them safe from more bleeding.

  Recruiting Pirogov Russian National Research Medical University · Moscow · NCT06753786

• Personalized blood thinner treatment for hip and knee replacement patients

  This study is testing if personalized blood thinner treatments can better prevent blood clots and bleeding in patients getting hip or knee replacements compared to standard treatments.

  Recruiting at 12 sites Phase 4 Leiden University Medical Center · Apeldoorn, Gelderland and 12 other locations · NCT06581965

• Comparing rivaroxaban and low-molecular weight heparin for preventing blood clots in patients with lower limb trauma

  This study is testing if a new blood thinner called rivaroxaban can prevent blood clots better than a standard treatment in patients with leg injuries who are at high risk for clots.

  Recruiting at 26 sites Phase 3 University Hospital, Angers · Agen and 36 other locations · NCT06195540

• Study on the safety and performance of Celect Platinum Vena Cava Filters

  This study is testing how safe and effective the Celect Platinum Vena Cava Filters are for patients over time after they've had them placed in their bodies.

  Recruiting at 7 sites Cook Group Incorporated · Los Angeles, California and 6 other locations · NCT05881798

• Using geko device to prevent blood clots in stroke patients

  This study is testing if the geko™ device can help prevent blood clots in stroke patients who can’t move around, compared to the standard treatment they usually get.

  Recruiting at 17 sites Firstkind Ltd · Bury St Edmunds, Suffolk and 17 other locations · NCT05476913

• TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization

  This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.

  Recruiting University of Monastir · Monastir · NCT07863115

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.